Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Senseonics Holdings (NY: SENS )

0.4917 -0.0040 (-0.81%)
Official Closing Price Updated: 8:00 PM EDT, May 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,490,385
Open 0.4778
Bid (Size) 0.4950 (9)
Ask (Size) 0.4960 (5)
Prev. Close 0.4957
Today's Range 0.4778 - 0.4950
52wk Range 0.3838 - 1.050
Shares Outstanding 530,886,421
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SENS Stock Earnings: Senseonics Holdings Meets EPS, Beats Revenue for Q1 2024
SENS stock results show that Senseonics Holdings met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire

Performance

YTD
-12.20%
-12.20%
1 Month
+12.49%
+12.49%
3 Month
-19.62%
-19.62%
6 Month
-18.79%
-18.79%
1 Year
-36.46%
-36.46%

More News

Read More
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
From Senseonics Holdings, Inc.
Via Business Wire
Recap: Senseonics Holdings Q4 Earnings
Via Benzinga
Earnings Scheduled For February 29, 2024
Via Benzinga
Recap: Senseonics Holdings Q3 Earnings
Via Benzinga
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Eversense® CGM System Receives iCGM Designation by the US FDA
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
From Senseonics Holdings, Inc.
Via Business Wire
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
From Senseonics Holdings, Inc.
Via Business Wire
3 Penny Stocks to Watch for Explosive Growth in Q1 2024
Via InvestorPlace
Senseonics Holdings, Inc. Announces Business Updates
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes
From Senseonics Holdings, Inc.
Via Business Wire
Danaher, Brooge Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
From Senseonics Holdings, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.